[{"Assets_0_Q2_USD":396703000.0,"CommonStockSharesOutstanding_0_Q2_shares":66039310.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19877000.0,"NetIncomeLoss_1_Q2_USD":-7669000.0,"NetIncomeLoss_2_Q2_USD":-15937000.0,"StockholdersEquity_0_Q2_USD":346130000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]